Written by Rupert Kircz | Wednesday, 11 February 2009 | There are 2 comments
The drug companies who produce the erectile dysfunction medications Viagra, Cialis and Levitra are in big trouble in Switzerland. The Swiss Competition Commission claims that they have been fixing the price of their medicines in the country and should therefore receive official sanction and fines.

Pfizer, Eli Lilly and Bayer AG have been accused of having “inadmissible vertical competition agreements” which inflated the price that the public had to pay for their respective medications. Oliver Schaller speaking on behalf of the Swiss Competition Commission said that recommended public selling prices were issued and used by the pharmacies and doctors who prescribed the impotence drugs.
In line with correct procedure Pfizer, Eli Lilly and Bayer AG have a twenty day period in which to file objections to the accusations after which the Swiss Competition Commission will be able to fine the companies and stop them from suggesting price tariffs for the medications.
Eli Lilly said that they were sure they had not contravened any of the laws regarding the sale and marketing of erectile dysfunction medication in Switzerland and would be defending their corner. Pfizer and Bayer AG did not release any statements citing that they needed to study the Swiss Competition Commission claims more carefully before commenting.
If the three drug companies are found guilty there will be a lot of red faces in their respective boardrooms. Price fixing is illegal in practically all countries and it is shocking that in a normally staid and conservative nation famous for its banks and mountains that such a despicable practice it should be flourishing especially in the area of medications.
Viagra, Cialis and Levitra have helped millions of men around the world regain erectile function and have made millions of pounds for their respective manufacturers. Viagra which is the best selling drug of the three is probably the most famous medications in the world.
